Third Amended Master Long Form Complaint - Dispute Resolution ...

More documents

Recommendations

Info

Sears Tower - Suite 5500Chicago, IL 60606GENERIC DEFENDANTS:Teva Pharmaceuticals USA, Inc.,Individually and d/b/a IVAXPharmaceuticalsMs. Jennifer Fuller-RicciardiTeva Pharmaceuticals USA, Inc.425 Privet RoadP.O. Box 1005Horsham, PA 19044Teva Pharmaceutical Industries, Ltd.Agent for Service of Process (CentralAuthority):The Director of CourtsDirectorate of Courts22 Kanfei Nesharin St.Jerusalem 95464P.O.B. 34142IsraelPLIVA, Inc., Individually and f/k/a SidmakLaboratories, Inc.Ms. Jennifer Fuller-RicciardiTeva Pharmaceuticals USA, Inc.425 Privet RoadP.O. Box 1005Horsham, PA 19044PLIVA d.d.Agent for Service of Process (CentralAuthority):Ministry of Justice of the Republic of CroatiaDezmanova 6 I 10CroatiaBarr Pharmaceuticals LLC f/k/a BarrPharmaceuticals, Inc.Ms. Jennifer Fuller-RicciardiTeva Pharmaceuticals USA, Inc.425 Privet RoadP.O. Box 1005Horsham, PA 19044- 4 -Case ID: 100101997
Page 1 and 2: IN RE ::COURT OF COMMON PLEASPHILAD
Page 6 and 7: Pharmaceutical Associates, Inc.Dani
Page 8 and 9: Actavis Group hfAgent for Service o
Page 10 and 11: Paco Pharmaceutical Services, Inc.,
Page 12 and 13: or claims asserted in those individ
Page 14 and 15: 9. Defendant Schwarz Pharma AG is a
Page 16 and 17: Pharma AG, UCB Pharma GmbH, Alaven
Page 18 and 19: 20. Defendant Barr Pharmaceuticals
Page 20 and 21: Boston, Massachusetts 02129 and Kri
Page 22 and 23: process by registered mail, return
Page 24 and 25: 37. Defendant Actavis Elizabeth LLC
Page 26 and 27: Corporation.Defendant regularly con
Page 28 and 29: equested, upon George S. Thomas Esq
Page 30 and 31: Corporation Trust Company, Corporat
Page 32 and 33: Individually and d/b/a IVAX Pharmac
Page 34 and 35: 71. Defendants Wyeth LLC and Wyeth
Page 36 and 37: 81. These involuntary movements are
Page 38 and 39: 93. Defendant Pfizer, Inc. has sinc
Page 40 and 41: the drug’s manufacturers, in its
Page 42 and 43: and after, through their own studie
Page 44 and 45: a. ensure Reglan, metoclopramide an
Page 46 and 47: proper language describing the natu
Page 48 and 49: 121. The FDA also ordered the DRUG
Page 50 and 51: V. Claims for ReliefCOUNT I - STRIC
Page 52 and 53: 1. Defendants, failed to communicat
Page 54 and 55:
143. At times material to these all
Page 56 and 57:
153. Pursuant to common law and/or
Page 58 and 59:
17. They failed to exercise ordinar
Page 60 and 61:
COUNT IV - NEGLIGENCE PER SE162. Pl
Page 62 and 63:
epresentatives (called detail men),
Page 64 and 65:
176. BRAND NAME DEFENDANTs made the
Page 66 and 67:
directly, and indirectly through as
Page 68 and 69:
DEFENDANTS, were expected to and di
Page 70 and 71:
28. They made false and misleading
Page 72 and 73:
COUNT X - CONSCIOUS or NEGLIGENT MI
Page 74 and 75:
c) There is no reason in general to
Page 76 and 77:
easonably but unjustifiably believi
Page 78 and 79:
230. Spouse Plaintiffs and/or Famil
Page 80 and 81:
244. The representatives/administra
Page 82 and 83:
251. The conduct of DRUG COMPANY DE
Page 84 and 85:
EQUITABLE TOLLING OF APPLICABLE STA
show all

Third Amended Master Long Form Complaint - Dispute Resolution ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?